Osteoporosis affects 10 million people in the United States, the majority of them women. Romosozumab is a new type of medication for treating osteoporosis that offers another treatment option for some women after menopause.
People over 50 who want to keep their bones healthy may be tempted to take calcium and/or vitamin D supplements, but recent research found that these are not likely to be effective; for most people, getting these nutrients from food is a better strategy.
As we age we lose bone strength, and the risk of a fracture becomes a serious concern. A study found that exercising for just a few minutes a day brought a reduction In risk for brittle bones.
Women who are especially active may be susceptible to a spectrum disorder known as the female athlete triad, a combination of symptoms rooted in inadequate nutrition that can ultimately lead to a greater risk of osteoporosis.
You may have seen the recent headlines proclaiming that tequila is good for bone health. While that sounds appealing to many, the truth is that there are many caveats to the study behind those headlines. This latest story is just one example of news articles that proclaim our favorite foods, like coffee and chocolate, are actually good for us. As with all these stories, it’s important to look deeper than the flashy headline.
In its early stages, osteoporosis has no symptoms but causes millions of bone fractures every year, often resulting in loss of function and, disability and even death from the complications of the fracture. There are effective medications to prevent osteoporosis, but they can have serious (though rare) side effects. It’s best to talk discuss with your doctor to understand all your options and make an informed decision on how to best protect your bones.
How much calcium do you really need for strong, healthy bones? The answer isn’t as clear as we once thought. Recent analyses suggest that neither dietary calcium nor calcium supplements reduce the risk of fractures. In the absence of a clear deficiency, it’s impossible to know how exactly much calcium a person needs. Ideally, you should get most of your calcium through food. Be sure you’re getting adequate vitamin D as well.
Over the past decade, a barrage of reports linking low vitamin D levels to cancer, heart disease, diabetes, and a host of other ills led many doctors to routinely test vitamin D levels in their healthy patients. But there is no good reason to do that, according to a new recommendation from the U.S. Preventive Services Task Force (USPSTF) published in this week’s Annals of Internal Medicine. The task force concluded that it isn’t helpful for most people to know their vitamin D level, and that even if you have a “low” vitamin D level there’s little evidence that taking a vitamin D supplement will do most people any good.
For women with osteoporosis who are embarking on a “holiday” from taking a bone-building drug, the message from a study released today is “Bon voyage—see you in two years or so.” After menopause, loss of bone (osteoporosis) can lead to crippling fractures of the hip and spine. Drugs called bisphosphonates—alendronate (Fosamax) was the first on the market in the mid-1990s—slow bone loss. But after taking these drugs for a number of years, the balance can begin to tip from help to harm. A new report from the Fracture Intervention Trial Long-term Extension (FLEX) shows that measuring bone density after one year added no information that would have helped doctors identify who was at risk and perhaps should start taking a bisphosphonate again. Waiting two years is a good option for most women.
One key instruction in the operating manual for healthy aging is remaining ever vigilant about osteoporosis. The quest to identify osteoporosis early has led to widespread testing of bone mineral density (BMD), the key measure of bone strength. Medicare pays for the gold-standard test, dual-energy X-ray absorptiometry (DEXA), every two years, regardless of whether their previous scan was normal or not. A study published today found that repeat bone-density testing after four years improved the ability to identify those at higher risk by only 4%. This study raises the fundamental question: Is repeating testing of older people with normal bone strength every two years too much?